Depomed Prevails Against Actavis In Gralise Case By: Benzinga via Benzinga August 19, 2014 at 11:14 AM EDT Shares of Depomed (NASDAQ: DEPO) are trading sharply higher following news of a favorable court ruling versus competitor Actavis ... Read More >> Related Stocks: Actavis Plc Depomed Inc